Dr. Hank Kaplan, MD

Claim this profile
Studies Breast cancer
Studies Breast Cancer
1 reported clinical trial
3 drugs studied

Area of expertise

1Breast Cancer
Hank Kaplan, MD has run 1 trial for Breast cancer. Some of their research focus areas include:
Stage III
Stage IV
HER2 positive
2Breast Cancer
Hank Kaplan, MD has run 1 trial for Breast Cancer. Some of their research focus areas include:
Stage III
Stage IV
HER2 positive

Clinical Trials Hank Kaplan, MD is currently running

More about Hank Kaplan, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Hank Kaplan, MD has experience with
  • Eribulin
  • Trastuzumab
  • Tucatinib
Breakdown of trials Hank Kaplan, MD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hank Kaplan, MD specialize in?
Hank Kaplan, MD focuses on Breast cancer and Breast Cancer. In particular, much of their work with Breast cancer has involved Stage III patients, or patients who are Stage IV.
Is Hank Kaplan, MD currently recruiting for clinical trials?
Yes, Hank Kaplan, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Hank Kaplan, MD has studied deeply?
Yes, Hank Kaplan, MD has studied treatments such as Eribulin, Trastuzumab, Tucatinib.
What is the best way to schedule an appointment with Hank Kaplan, MD?
Apply for one of the trials that Hank Kaplan, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.